Monoacylglycerol acyltransferase 1 (MOGAT1) was increased by 1.5-fold in MetS+ subjects’ SAT, while glucose transporter 1 (GLUT1) mRNA levels were higher (1.33-fold) in VAT (Table 3 and Supplementary Table S2). Here, SLC2A1 is linked to metabolic syndrome.